Education on managing thyroid nodules
Official title: Decision Aid for Management of Thyroid Nodules and Early Thyroid Cancer
Run by Stony Brook University · NCT05264857 · Data updated 2026-11-12
This study is testing how providing information on managing small thyroid nodules helps patients feel more satisfied with their treatment choices.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 134 (estimated) |
| Sponsor | Stony Brook University Academic / other |
| Locations | 1 site (Stony Brook, New York) |
| Status | Recruiting |
| Started | February 8, 2022 |
| Main results expected | September 30, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | October 14, 2025 |
| Trial ID | NCT05264857 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals with indeterminate or malignant thyroid nodules that are 2cm or smaller.
✕Probably not a fit
Patients with a history of thyroid surgery or thyroid cancer may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study provides patients with small, favorable malignant or indeterminate thyroid nodules with information regarding their management options. Participants will complete surveys at enrollment, after their consultation with a surgeon, and a few months post-consultation or surgery to evaluate their satisfaction with the decision-making process. All participants will receive standard care and counseling from their endocrinologist and surgeon throughout the study.
Why it matters
Potential benefit: If successful, this study could enhance patient understanding and satisfaction in managing thyroid nodules.
How similar studies have gone: While similar studies have explored patient education in thyroid management, this specific approach focusing on decision aids for small nodules is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Histology showing indeterminate or malignant thyroid pathology (Bethesda III-VI) * Thyroid nodule size less or equal to 2cm Exclusion Criteria: * History of thyroid surgery * History of thyroid cancer
Where it's running
-
Stony Brook University Cancer Center
Stony Brook, New York, United States Recruiting
Study contacts
- Principal investigator: Lukasz Czerwonka, MD — Lukasz.Czerwonka@stonybrookmedicine.edu
- Study coordinator: Jessica Alfano
- Email: jessica.alfano@stonybrookmedicine.edu
- Phone: 631-216-2993
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NIRAF-guided identification of parathyroids during thyroidectomy
A wearable near-infrared autofluorescence device is being tested to help surgeons find and protect the parathyroid glands during thyroid surgery in adults.
-
Combining ultrasound and cytology whole-slide images to predict cancer risk in indeterminate (Bethesda III) thyroid nodules
This project will test whether a deep learning model that merges ultrasound pictures and cytology whole-slide images can better predict which Bethesda III thyroid nodules are cancerous.
-
Low calcium after thyroid removal
This project will see if clinical, lab, and surgical factors predict low calcium after thyroid surgery in adults treated at Minia University Hospital from 2014–2024.
-
Active monitoring for small Bethesda IV thyroid nodules
This program will try active monitoring with scheduled ultrasounds and clinic visits instead of immediate surgery for adults with a single Bethesda IV thyroid nodule under 2 cm.
-
Multiparametric ultrasound imaging for pancreatic risk screening and thyroid nodules
This project will try multiparametric ultrasound (mpUS) to see if it gives clearer pictures of pancreatic tissue for people at high risk for pancreatic cancer and of thyroid nodules for people being evaluated for those lumps.
-
Using radiofrequency ablation to treat low-risk thyroid cancer
This study is testing if a new treatment called radiofrequency ablation can safely help people with low-risk thyroid cancer that is 2 cm or smaller instead of traditional surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.